Platinum-Sensitive Ovarian Cancer in First Relapse
1 competing product in clinical development for Platinum-Sensitive Ovarian Cancer in First Relapse.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Farletuzumab + Placebo | Eisai | Phase 2 | Completed | 35 |